Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2007
07/05/2007US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid
07/05/2007US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine
07/05/2007US20070155783 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
07/05/2007US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine
07/05/2007US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto
07/05/2007US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
07/05/2007US20070155759 Using 1-acylpiperidine substance P antagonists; gastrointestinal disorders, analgesics, antiinflammatory agents, central nervous system disorders, rheumatic diseases
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression
07/05/2007US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
07/05/2007US20070155713 Nitrogen-containing heterocyclic compounds and use thereof
07/05/2007US20070155676 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols
07/05/2007US20070155675 Substituted azetidinone compunds, processes for preparing the same, formulations and uses thereof
07/05/2007US20070155674 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
07/05/2007US20070155657 Hypoglycemic agent
07/05/2007US20070155656 Hypoglycemic agent
07/05/2007US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes
07/05/2007US20070155654 Novel formulations
07/05/2007US20070155653 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.2% by weight of zinc based on the insulin content of the formulation; Polypeptide mixture containing preservative, surfactant and stabilizer
07/05/2007US20070154912 87 Human Secreted Proteins
07/05/2007US20070154548 Controlled release metformin formulations
07/05/2007CA2635777A1 Combination therapy for diabetes
07/05/2007CA2634940A1 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
07/05/2007CA2634833A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp)
07/05/2007CA2634437A1 4,7-dihydrothieno¬2,3-b|pyridine compounds and pharmaceutical compositions
07/05/2007CA2634235A1 Combination of an h3 antagonist/inverse agonist and an appetite suppressant
07/05/2007CA2634093A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
07/05/2007CA2633993A1 Phytosterols for use in reducing c-reactive protein levels
07/05/2007CA2633608A1 Long term weight maintenance
07/05/2007CA2633584A1 Glucokinase activators
07/05/2007CA2633070A1 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
07/05/2007CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity
07/04/2007EP1803810A1 Integrin antagonists
07/04/2007EP1803730A1 Albumin fusion proteins
07/04/2007EP1803729A1 1-( -d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof
07/04/2007EP1803721A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
07/04/2007EP1803714A1 Process for preparing crystalline forms of orlistat
07/04/2007EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring
07/04/2007EP1803452A1 Ester derivative and pharmaceutical use thereof
07/04/2007EP1803451A1 Pufa supplements
07/04/2007EP1803440A1 Pharmaceutical formulation comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa)
07/04/2007EP1802747A2 Delta 6-desaturase genes and uses thereof
07/04/2007EP1802623A1 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
07/04/2007EP1802612A1 Novel b1 bradykinin receptor antagonists
07/04/2007EP1802582A1 Benzamide derivatives that act upon the glucokinase enzyme.
07/04/2007EP1802571A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
07/04/2007EP1802329A1 A pharmaceutical formulation comprising crystalline insulin and dissolved insulin
07/04/2007EP1802324A1 Intestinal epithelial glucose sensor
07/04/2007EP1802308A1 Combination of organic compounds
07/04/2007EP1469843B1 Composition for pharmaceutical or dietetic use for combating hair loss
07/04/2007EP1375496B1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
07/04/2007EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
07/04/2007EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions
07/04/2007EP1054594B1 Inotropic and diuretic effects of exendin and glp-1
07/04/2007EP0994716B2 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body
07/04/2007CN1993463A Follistatin mutant polypeptide
07/04/2007CN1993360A Condensed pyridines as kinase inhibitors
07/04/2007CN1993343A Tetracyclic compounds as estrogen ligands
07/04/2007CN1993336A Substituted n-acyl-2-aminothiazoles
07/04/2007CN1993323A Indole, indazole or indoline derivatives
07/04/2007CN1993122A Cholesterol lowering supplement and low cholesterol egg produced by using the same
07/04/2007CN1990487A Berberine ion pair compound, preparing method and drug containing same
07/04/2007CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor
07/04/2007CN1990481A Scutellarein derivative, its preparing process and application
07/04/2007CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
07/04/2007CN1990471A Mch antagonists and their use in the treatment of obesity
07/04/2007CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990447A Keton of Gentianopsis Paludosa Ma and its derivative, and preparing method and use thereof
07/04/2007CN1990033A Drug for treating hypertension, dense blood and arteriosclerosis
07/04/2007CN1990014A Cordyceps militaris fat expelling element and process for manufacturing same
07/04/2007CN1989975A Method for preparing composite injection of 12 vitamins
07/04/2007CN1989880A Traditional Chinese medicine health care pillow
07/04/2007CN1324040C Medicament for treating diabetes, diabetes complication, its preparation and novel use
07/04/2007CN1324029C Amino biological pterin derivative and pharmaceutical use thereof
07/04/2007CN1324025C Tropane derivatives as CCR5 modulators
07/04/2007CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
07/04/2007CN1324019C New azadicyclo salt kind compound and its use in treating protein aging disease
07/04/2007CN1324015C Pyridine and pyrimidine derivatives
07/04/2007CN1324013C Aryl Fused azapolycyclic compounds
07/04/2007CN1324004C New phenyl-naphthalene derivatives, and preparation method and drug containing same
07/04/2007CN1324001C Novel thyroid receptor ligands
07/04/2007CN1323694C Compound dripping pills contg. fruit of Chinese haw-thorn, and its prepn. method
07/04/2007CN1323687C Blood supplementing iron supplementing medicineal preparation and its preparation method
07/04/2007CN1323678C Diabetes treating pharmaceutical compositions and its preparing method
07/04/2007CN1323675C Novel usage of chicory aqueous extract
07/04/2007CN1323674C Arctium fruit general lignin glycoside extracts for treating diabetic nephrosis or diabete
07/04/2007CN1323665C Composition for treating hyperlipemia
07/04/2007CN1323612C Method for extracting Vitamin B from wheat bran
07/03/2007US7238811 Chemical compounds
07/03/2007US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor
07/03/2007US7238727 Compositions for improving lipid metabolism
07/03/2007US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/03/2007US7238723 Indole derivatives
07/03/2007US7238720 Pharmaceutical use of N-carbamoylazole derivatives
07/03/2007US7238718 Method for treating myolytic disease and method for screening antimyolytic agent
07/03/2007US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
07/03/2007US7238716 Alkanoic acid derivatives process for their production and use thereof
07/03/2007US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/03/2007US7238695 Imidazolyl derivatives